Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

Lamerato LE, Marcus PM, Jacobsen G, Johnson CC.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):827-33. doi: 10.1158/1055-9965.EPI-06-0528.

2.

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S.

PMID:
11189683
3.

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.

Simpson NK, Johnson CC, Ogden SL, Gamito E, Trocky N, McGuire C, Martin J, Barrow S, Lamerato L, Flickinger LM, Broski KG, Engelhard D, Hilke C, Bonk J, Gahagan B, Gren LH, Childs J, Lappe K, Fouad M, Thompson J, Sullivan D; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):356S-378S.

PMID:
11189688
4.

Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Stallings FL, Ford ME, Simpson NK, Fouad M, Jernigan JC, Trauth JM, Miller DS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):379S-389S.

PMID:
11189689
5.

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.

Gren LH, Lamerato LE, Wright P, Marcus PM.

Rev Recent Clin Trials. 2015;10(3):194-9. Review.

PMID:
26238206
6.

Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Pinsky PF, Ford M, Gamito E, Higgins D, Jenkins V, Lamerato L, Tenorio S, Marcus PM, Gohagan JK.

J Natl Med Assoc. 2008 Mar;100(3):291-8.

PMID:
18390022
7.

Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Gren L, Broski K, Childs J, Cordes J, Engelhard D, Gahagan B, Gamito E, Gardner V, Geisser M, Higgins D, Jenkins V, Lamerato L, Lappe K, Lowery H, McGuire C, Miedzinski M, Ogden S, Tenorio S, Watt G, Wohlers B, Marcus P.

Clin Trials. 2009 Feb;6(1):52-9. doi: 10.1177/1740774508100974.

8.

Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.

Trauth JM, Jernigan JC, Siminoff LA, Musa D, Neal-Ferguson D, Weissfeld J.

J Clin Oncol. 2005 Dec 1;23(34):8730-8.

PMID:
16314633
9.

Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial.

Gohagan JK, Broski K, Gren LH, Fouad MN, Higgins D, Lappe K, Ogden S, Shambaugh V, Pinsky PF, O'Brien B, Yurgalevich S, Riley T, Wright P, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):187-93. Review.

PMID:
26435288
10.

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB, Yurgalevitch S, Weissfeld JL; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):400S-406S.

PMID:
11189691
11.

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team..

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.

12.

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler RG, Johnson CC, Weissfeld JL, Hoover RN, Hartge P, Palace C, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):349S-355S.

PMID:
11189687
13.

Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Weissfeld JL, Fagerstrom RM, O'Brien B; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):390S-399S.

PMID:
11189690
14.

Data Processing and Analytic Support in the PLCO Cancer Screening Trial.

Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):233-7. Review.

PMID:
26238116
15.

Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Andriole GL.

Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6.

PMID:
24531777
16.

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S.

PMID:
11189684
17.

Comprehensive Quality Management (CQM) in the PLCO Trial.

Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC.

Rev Recent Clin Trials. 2015;10(3):223-32.

PMID:
26238118
18.

Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

O'Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team..

Control Clin Trials. 2000 Dec;21(6 Suppl):310S-328S.

PMID:
11189685
19.

Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.

Taylor KL, Shelby R, Gelmann E, McGuire C.

J Natl Cancer Inst. 2004 Jul 21;96(14):1083-94.

PMID:
15265970
20.

Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T.

Prev Med. 2014 Oct;67:82-8. doi: 10.1016/j.ypmed.2014.07.013. Epub 2014 Jul 16.

Supplemental Content

Support Center